2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors

Details 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors

2005-12-06

2010-10-12

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252140, C514S275000, C544S122000, C544S295000, C544S331000

Reexamination Certificate

active

07812022

ABSTRACT:
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.

REFERENCES:
patent: 6727256 (2004-04-01), Carter et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6919352 (2005-07-01), Chamberlain et al.
patent: 6962914 (2005-11-01), Gudmundsson et al.
patent: 7141569 (2006-11-01), Cheung et al.
patent: 7153863 (2006-12-01), Gudmundsson et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 9935146 (1999-07-01), None
patent: 0216359 (2002-02-01), None
patent: 2004/021988 (2004-03-01), None
patent: 2005/068452 (2005-07-01), None
patent: 2006068826 (2006-06-01), None
Traxler, Protein Tyrosine Kinase Inhibitors in Cancer Treatment, Expert Opinion on Therapeutic Patents, 7(6):571-588, 1997.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
R. Hubbard, et al.,; Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-1R); Bioorganic & Med Chem Lttrs; Jul. 25, 2007; 17: 5406-5409.

Affiliated with

Also associated with

Rating

2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4181938